Latest News

Common multiple sclerosis drugs taken together do not reduce relapse risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Unraveling the enigma of salty taste detection

  • Tiny worm opens big discovery on nerve degeneration

  • Mobile communication keeps couples who live close to one another even closer

  • Scientists learn how young brains form lifelong memories by studying worms' food choices

  • Memory replay prioritizes high-reward memories

  • Starfish reveal the origins of brain messenger molecules

  • Alcohol-impaired driving crimes spike immediately after drinking age

  • Blocking stress protein relieves chronic pain in mice

  • Why you may skimp on your Valentine's Day gift

  • Daters move toward (or away from) marriage in four different ways: Where do you fit?

  •